Alterity Therapeutics analyst ratings
Alterity Therapeutics analyst ratings
While ratings are subjective and will change, the latest Alterity Therapeutics (ATHE) rating was a initiated with a price target of $0.00 to $2.00. The current price Alterity Therapeutics (ATHE) is trading at is $0.59, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/03/2022 | 239.79% | Ladenburg Thalmann | → $2 | Initiates Coverage On | → Buy |
| 06/23/2022 | 409.68% | Goldman Sachs | $11 → $3 | Maintains | Neutral |
| 08/20/2021 | 579.58% | Benchmark | → $4 | Initiates Coverage On | → Speculative Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 08/03/2022 | 239.79% | 拉登堡·塔爾曼 | → $2 | 開始承保 | →購買 |
| 06/23/2022 | 409.68% | 高盛 | $11 → $3 | 維護 | 中性 |
| 08/20/2021 | 579.58% | 基準 | → $4 | 開始承保 | →投機性買入 |
Alterity Therapeutics Questions & Answers
交替治療學問答
The latest price target for Alterity Therapeutics (NASDAQ: ATHE) was reported by Ladenburg Thalmann on August 3, 2022. The analyst firm set a price target for $2.00 expecting ATHE to rise to within 12 months (a possible 239.79% upside). 3 analyst firms have reported ratings in the last year.
拉登堡·塔爾曼於2022年8月3日報道了Alterity治療公司(納斯達克：Athe)的最新目標價。這家分析公司將目標價定為2美元，預計A股將在12個月內上漲至12個月內(可能上漲239.79)。3家分析公司在過去一年公佈了評級。
The latest analyst rating for Alterity Therapeutics (NASDAQ: ATHE) was provided by Ladenburg Thalmann, and Alterity Therapeutics initiated their buy rating.
Alterity治療公司(納斯達克代碼：Athe)的最新分析師評級由拉登堡·塔爾曼提供，Alterity治療公司啟動了他們的買入評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alterity Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alterity Therapeutics was filed on August 3, 2022 so you should expect the next rating to be made available sometime around August 3, 2023.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閲公共財務報表，與Alterity Treeutics的高管和客户交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Alterity治療公司的上一次評級是在2022年8月3日提交的，所以你應該預計下一次評級將在2023年8月3日左右的某個時候提供。
While ratings are subjective and will change, the latest Alterity Therapeutics (ATHE) rating was a initiated with a price target of $0.00 to $2.00. The current price Alterity Therapeutics (ATHE) is trading at is $0.59, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Alterity Treateutics(Athe)評級是以0.00美元至2.00美元的目標價啟動的。Alterity Treateutics(Athe)目前的交易價格為0.59美元，在分析師的預測範圍內。
